Decoding the mechanism of andrographolide to combat hepatocellular carcinoma: a network pharmacology integrated molecular docking and dynamics approach

被引:6
|
作者
Dixit, Nandan [1 ]
Motwani, Harsha [1 ]
Patel, Saumya K. [1 ]
Rawal, Rakesh M. [2 ]
Solanki, Hiteshkumar A. [1 ]
机构
[1] Gujarat Univ, Dept Bot Bioinformat & Climate Change Impacts Mana, Ahmadabad, Gujarat, India
[2] Gujarat Univ, Sch Sci, Dept Life Sci, Ahmadabad, Gujarat, India
来源
关键词
hepatoCellular carcinoma; andrographolide; network pharmacology; molecular docking and molecular dynamic simulation; STEM-CELL DIFFERENTIATION; NATURAL-PRODUCTS; CANCER-CELLS; PANICULATA; GENES; TOOL; BIOINFORMATICS; IDENTIFICATION; INHIBITION; ANNOTATION;
D O I
10.1080/07391102.2023.2256866
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HepatoCellular Carcinoma, being one of the most mortally convoluted malignancy with mounting number of occurrences across the world and being classified as the third most prevalent cause of cancer-associated mortalities and sixth most prevalent neoplasia. The active phytoconstituent andrographolide, derived from Andrographis paniculata is conveyed to reconcile a number of human ailments including various oncologies. However, the molecular mechanism underlying the anti-oncogenic effects of Andrographolide on HCC remains skeptical and unclear, emerging as a budding challenge for researchers and oncologists. The present study intends to analyze the underlying pharmacological mechanism of Andrographolide over HCC, established via assimilated approach of network pharmacology. Herein, the Network pharmacology stratagem was instigated to investigate potential HCC targets. The Andrographolide targets along with HCC targets were extracted from multiple databases. A total of 162 potential overlapping targets among HCC and Andrographolide were obtained and further subjected to gene ontology and Pathway enrichment analysis by employing OmicsBox and DAVID database, respectively. Subsequently, Protein-protein interaction network construction by Cytoscape software identified the top 10 hub nodes which were validated by survival and expression analysis. Further, the results derived from molecular docking and dynamic simulations by CB-Dock2 server and Desmond module (Schrodinger software) indicate ALB, CCND1, HIF1A, TNF, and VEGFA as potential Andrographolide related targets with high binding affinity and promising complex stability. Our findings not only reveal the antioncogenic role of andrographolide but also provide novel insights illuminating the identified targets as scientific foundation for anti-oncogenic clinical application of andrographolide in HCC therapeutics.Communicated by Ramaswamy H. Sarma
引用
收藏
页码:10237 / 10255
页数:19
相关论文
共 50 条
  • [1] [In absentia] unveiling the antioncogenic effect of rosmarinic acid (RosA) on hepatocellular carcinoma: an integrated network pharmacology, molecular docking, and dynamics approach
    Dixit, Nandan
    Motwani, Harsha
    Patel, Saumya K.
    Rawal, Rakesh M.
    Solanki, Hiteshkumar A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 : 14 - 15
  • [2] Exploring the mechanism of genistein in treating hepatocellular carcinoma through network pharmacology and molecular docking
    Wang, Siliang
    Chen, Wenlian
    Dong, Changsheng
    Wu, Jia
    Zheng, Miaomiao
    Ma, Yushui
    Xue, Yuwen
    ONCOLOGIE, 2024, 26 (05) : 799 - 811
  • [3] Underlying Mechanisms of Bergenia spp. to Treat Hepatocellular Carcinoma Using an Integrated Network Pharmacology and Molecular Docking Approach
    Hussain, Shoukat
    Mustafa, Ghulam
    Ahmed, Sibtain
    Albeshr, Mohammed Fahad
    PHARMACEUTICALS, 2023, 16 (09)
  • [4] Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking
    Yadav, Ravi Prakash
    Sadhukhan, Susanta
    Saha, Makhan Lal
    Ghosh, Sudakshina
    Das, Madhusudan
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking
    Ravi Prakash Yadav
    Susanta Sadhukhan
    Makhan Lal Saha
    Sudakshina Ghosh
    Madhusudan Das
    Scientific Reports, 12
  • [6] Mechanism of atorvastatin in treating hepatocellular carcinoma: a study based on network pharmacology, molecular docking, and bioinformatics analysis
    Hu, Youwen
    Xiao, Yangyang
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, : 5693 - 5703
  • [7] Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A
    Luo, Qing
    Shi, Xuan
    Ding, Jiarong
    Ma, Zhenzhen
    Chen, Xumei
    Leng, Yuanxiu
    Zhang, Xuhui
    Liu, Yang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [8] Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology
    Yang, Miaolun
    Yan, Qian
    Luo, Yuehua
    Wang, Boqing
    Deng, Shicong
    Luo, Huiyan
    Ye, Baoqian
    Wang, Xiongwen
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] Integrated network pharmacology, proteomics, molecular docking, and experiments in vivo and in vitro to explore the efficacy and potential mechanism of bufalin against hepatocellular carcinoma angiogenesis
    Li, Yuanchao
    Zhou, Lingwei
    Sun, Kang
    Guo, Ran
    Li, Zehua
    Wen, Qingqing
    Fu, Guifeng
    Yang, Shuohui
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 345
  • [10] Network pharmacology integrated with molecular docking and molecular dynamics simulations to explore the mechanism of Tongxie Yaofang in the treatment of ulcerative colitis
    Tang, Lili
    Liu, Yuedong
    Tao, Hongwu
    Feng, Wenzhe
    Ren, Cong
    MEDICINE, 2024, 103 (36)